Kenmerk
Hip dislocation
Displacement of the femur from its normal location in the hip joint.
Samenvatting
- Ook bekend als
- Dislocated hips, Dislocation of hip, Dislocated femoral heads, Dislocation of the femoral head
ReferentiegenoomGRCh38hg38
Posities op gen- en variantpagina's volgen deze keuze, in deze browser.
Read the genes linked to Hip dislocation, and the rest of your genome, with one test.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken
Mijn Genome Test bestellen207 genen gekoppeld aan Hip dislocation
Veranderingen in deze genen veroorzaken zeldzame aandoeningen waarbij Hip dislocation voorkomt. De meeste mensen met dit kenmerk hebben geen van die aandoeningen, en een gen op deze lijst zegt niets over het eigen genoom van iemand.
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| AEBP1AE binding protein 1 | Altijd | In 2 aandoeningen |
| ARNT2aryl hydrocarbon receptor nuclear translocator 2 | Altijd | In 1 aandoening |
| COL1A2collagen type I alpha 2 chain | Altijd | In 2 aandoeningen |
| COL27A1collagen type XXVII alpha 1 chain | Altijd | In 1 aandoening |
| COX8Acytochrome c oxidase subunit 8A | Altijd | In 1 aandoening |
| CRNKL1crooked neck pre-mRNA splicing factor 1 | Altijd | In 1 aandoening |
| DONSONDNA replication fork stabilization factor DONSON | Altijd | In 1 aandoening |
| DVL1dishevelled segment polarity protein 1 | Altijd | In 2 aandoeningen |
| ERCC1ERCC excision repair 1, endonuclease non-catalytic subunit | Altijd | In 1 aandoening |
| ERI1exoribonuclease 1 | Altijd | In 1 aandoening |
| EXOC6Bexocyst complex component 6B | Altijd | In 1 aandoening |
| GSCgoosecoid homeobox | Altijd | In 1 aandoening |
| HNRNPH1heterogeneous nuclear ribonucleoprotein H1 | Altijd | In 1 aandoening |
| IARS2isoleucyl-tRNA synthetase 2, mitochondrial | Altijd | In 2 aandoeningen |
| IL6STinterleukin 6 cytokine family signal transducer | Altijd | In 1 aandoening |
| MED16mediator complex subunit 16 | Altijd | In 1 aandoening |
| POLR3BRNA polymerase III subunit B | Altijd | In 1 aandoening |
| RNU5B-1RNA, U5B small nuclear 1 | Altijd | In 1 aandoening |
| SEC31ASEC31 homolog A, COPII component | Altijd | In 1 aandoening |
| SLC35A3solute carrier family 35 member A3 | Altijd | In 2 aandoeningen |
| TBX15T-box transcription factor 15 | Altijd | In 1 aandoening |
| TOR1Atorsin family 1 member A | Altijd | In 1 aandoening |
| TRIM8tripartite motif containing 8 | Altijd | In 1 aandoening |
| UBA2ubiquitin like modifier activating enzyme 2 | Altijd | In 1 aandoening |
| UNC13Aunc-13 homolog A | Altijd | In 1 aandoening |
| COL1A1collagen type I alpha 1 chain | Heel vaak (80–99%) | In 2 aandoeningen |
| FLNBfilamin B | Heel vaak (80–99%) | In 2 aandoeningen |
| SOX9SRY-box transcription factor 9 | Heel vaak (80–99%) | In 2 aandoeningen |
| AARS1alanyl-tRNA synthetase 1 | Vaak (30–79%) | In 1 aandoening |
| ALDH18A1aldehyde dehydrogenase 18 family member A1 | Vaak (30–79%) | In 3 aandoeningen |
| ALG9ALG9 alpha-1,2-mannosyltransferase | Vaak (30–79%) | In 1 aandoening |
| ATP6V1AATPase H+ transporting V1 subunit A | Vaak (30–79%) | In 1 aandoening |
| B3GALT6beta-1,3-galactosyltransferase 6 | Vaak (30–79%) | In 2 aandoeningen |
| BICD2BICD cargo adaptor 2 | Vaak (30–79%) | In 1 aandoening |
| CCDC47coiled-coil domain containing 47 | Vaak (30–79%) | In 1 aandoening |
| COL12A1collagen type XII alpha 1 chain | Vaak (30–79%) | In 2 aandoeningen |
| COL6A1collagen type VI alpha 1 chain | Vaak (30–79%) | In 2 aandoeningen |
| COL6A2collagen type VI alpha 2 chain | Vaak (30–79%) | In 2 aandoeningen |
| COL6A3collagen type VI alpha 3 chain | Vaak (30–79%) | In 1 aandoening |
| DHCR77-dehydrocholesterol reductase | Vaak (30–79%) | In 2 aandoeningen |
Toon nog 167 genen
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| FIG4FIG4 phosphoinositide 5-phosphatase | Vaak (30–79%) | In 2 aandoeningen |
| FLNAfilamin A | Vaak (30–79%) | In 3 aandoeningen |
| FUT8fucosyltransferase 8 | Vaak (30–79%) | In 1 aandoening |
| GDF5growth differentiation factor 5 | Vaak (30–79%) | In 2 aandoeningen |
| GLI3GLI family zinc finger 3 | Vaak (30–79%) | In 3 aandoeningen |
| GORABgolgin, RAB6 interacting | Vaak (30–79%) | In 1 aandoening |
| HACE1HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | Vaak (30–79%) | In 2 aandoeningen |
| HDAC4histone deacetylase 4 | Vaak (30–79%) | In 1 aandoening |
| KDM6Alysine demethylase 6A | Vaak (30–79%) | In 2 aandoeningen |
| LMNAlamin A/C | Vaak (30–79%) | In 1 aandoening |
| MCTP2multiple C2 and transmembrane domain containing 2 | Vaak (30–79%) | In 1 aandoening |
| NKX3-2NK3 homeobox 2 | Vaak (30–79%) | In 1 aandoening |
| PLOD1procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 | Vaak (30–79%) | In 1 aandoening |
| PTRH2peptidyl-tRNA hydrolase 2 | Vaak (30–79%) | In 1 aandoening |
| PYCR1pyrroline-5-carboxylate reductase 1 | Vaak (30–79%) | In 2 aandoeningen |
| RBM8ARNA binding motif protein 8A | Vaak (30–79%) | In 2 aandoeningen |
| RNU4ATACRNA, U4atac small nuclear | Vaak (30–79%) | In 2 aandoeningen |
| RUNX2RUNX family transcription factor 2 | Vaak (30–79%) | In 1 aandoening |
| RYR3ryanodine receptor 3 | Vaak (30–79%) | In 1 aandoening |
| SIL1SIL1 nucleotide exchange factor | Vaak (30–79%) | In 1 aandoening |
| SPARCsecreted protein acidic and cysteine rich | Vaak (30–79%) | In 1 aandoening |
| WDR83OSWD repeat domain 83 opposite strand | Vaak (30–79%) | In 1 aandoening |
| XYLT1xylosyltransferase 1 | Vaak (30–79%) | In 1 aandoening |
| ZMPSTE24zinc metallopeptidase STE24 | Vaak (30–79%) | In 1 aandoening |
| ACTA1actin alpha 1, skeletal muscle | Soms (5–29%) | In 1 aandoening |
| AFF3ALF transcription elongation factor 3 | Soms (5–29%) | In 1 aandoening |
| AKT1AKT serine/threonine kinase 1 | Soms (5–29%) | In 1 aandoening |
| APCAPC regulator of Wnt signaling pathway | Soms (5–29%) | In 1 aandoening |
| ATAD1ATPase family AAA domain containing 1 | Soms (5–29%) | In 1 aandoening |
| ATP7AATPase copper transporting alpha | Soms (5–29%) | In 1 aandoening |
| BRCA1BRCA1 DNA repair associated | Soms (5–29%) | In 1 aandoening |
| BRCA2BRCA2 DNA repair associated | Soms (5–29%) | In 1 aandoening |
| BRD4bromodomain containing 4 | Soms (5–29%) | In 1 aandoening |
| BRIP1BRCA1 interacting DNA helicase 1 | Soms (5–29%) | In 1 aandoening |
| CDONcell adhesion associated, oncogene regulated | Soms (5–29%) | In 4 aandoeningen |
| CEP85Lcentrosomal protein 85L | Soms (5–29%) | In 1 aandoening |
| CFL2cofilin 2 | Soms (5–29%) | In 1 aandoening |
| COL25A1collagen type XXV alpha 1 chain | Soms (5–29%) | In 1 aandoening |
| COL5A1collagen type V alpha 1 chain | Soms (5–29%) | In 1 aandoening |
| COL5A2collagen type V alpha 2 chain | Soms (5–29%) | In 1 aandoening |
| COLEC10collectin subfamily member 10 | Soms (5–29%) | In 1 aandoening |
| COLEC11collectin subfamily member 11 | Soms (5–29%) | In 2 aandoeningen |
| CRIPTOcripto, EGF-CFC family member | Soms (5–29%) | In 4 aandoeningen |
| DISP1dispatched RND transporter family member 1 | Soms (5–29%) | In 4 aandoeningen |
| DLL1delta like canonical Notch ligand 1 | Soms (5–29%) | In 4 aandoeningen |
| DPYSL5dihydropyrimidinase like 5 | Soms (5–29%) | In 1 aandoening |
| DSTYKdual serine/threonine and tyrosine protein kinase | Soms (5–29%) | In 1 aandoening |
| DVL3dishevelled segment polarity protein 3 | Soms (5–29%) | In 1 aandoening |
| EBPEBP cholestenol delta-isomerase | Soms (5–29%) | In 1 aandoening |
| EFEMP2EGF-like fibulin extracellular matrix protein 2 | Soms (5–29%) | In 1 aandoening |
| EIF4A3eukaryotic translation initiation factor 4A3 | Soms (5–29%) | In 1 aandoening |
| ELNelastin | Soms (5–29%) | In 1 aandoening |
| ERCC4ERCC excision repair 4, endonuclease catalytic subunit | Soms (5–29%) | In 1 aandoening |
| ERGIC1endoplasmic reticulum-golgi intermediate compartment 1 | Soms (5–29%) | In 1 aandoening |
| FAAP100FA core complex associated protein 100 | Soms (5–29%) | In 1 aandoening |
| FANCAFA complementation group A | Soms (5–29%) | In 1 aandoening |
| FANCBFA complementation group B | Soms (5–29%) | In 2 aandoeningen |
| FANCCFA complementation group C | Soms (5–29%) | In 1 aandoening |
| FANCD2FA complementation group D2 | Soms (5–29%) | In 1 aandoening |
| FANCEFA complementation group E | Soms (5–29%) | In 1 aandoening |
| FANCFFA complementation group F | Soms (5–29%) | In 1 aandoening |
| FANCGFA complementation group G | Soms (5–29%) | In 1 aandoening |
| FANCIFA complementation group I | Soms (5–29%) | In 1 aandoening |
| FANCLFA complementation group L | Soms (5–29%) | In 1 aandoening |
| FANCMFA complementation group M | Soms (5–29%) | In 1 aandoening |
| FBLN5fibulin 5 | Soms (5–29%) | In 2 aandoeningen |
| FBXO22F-box protein 22 | Soms (5–29%) | In 1 aandoening |
| FGF8fibroblast growth factor 8 | Soms (5–29%) | In 4 aandoeningen |
| FGFR1fibroblast growth factor receptor 1 | Soms (5–29%) | In 2 aandoeningen |
| FKRPfukutin related protein | Soms (5–29%) | In 1 aandoening |
| FLI1Fli-1 proto-oncogene, ETS transcription factor | Soms (5–29%) | In 1 aandoening |
| FOXH1forkhead box H1 | Soms (5–29%) | In 4 aandoeningen |
| FZD2frizzled class receptor 2 | Soms (5–29%) | In 1 aandoening |
| GAS1growth arrest specific 1 | Soms (5–29%) | In 4 aandoeningen |
| GLI2GLI family zinc finger 2 | Soms (5–29%) | In 4 aandoeningen |
| GLRA1glycine receptor alpha 1 | Soms (5–29%) | In 2 aandoeningen |
| GLRBglycine receptor beta | Soms (5–29%) | In 1 aandoening |
| GMPPBGDP-mannose pyrophosphorylase B | Soms (5–29%) | In 1 aandoening |
| GNPTABN-acetylglucosamine-1-phosphate transferase subunits alpha and beta | Soms (5–29%) | In 2 aandoeningen |
| GPHNgephyrin | Soms (5–29%) | In 2 aandoeningen |
| HDAC8histone deacetylase 8 | Soms (5–29%) | In 1 aandoening |
| HK1hexokinase 1 | Soms (5–29%) | In 1 aandoening |
| HPRT1hypoxanthine phosphoribosyltransferase 1 | Soms (5–29%) | In 1 aandoening |
| IPO8importin 8 | Soms (5–29%) | In 1 aandoening |
| KANSL1KAT8 regulatory NSL complex subunit 1 | Soms (5–29%) | In 1 aandoening |
| KIF22kinesin family member 22 | Soms (5–29%) | In 2 aandoeningen |
| KLHL41kelch like family member 41 | Soms (5–29%) | In 1 aandoening |
| KMT2Dlysine methyltransferase 2D | Soms (5–29%) | In 1 aandoening |
| LARGE1LARGE xylosyl- and glucuronyltransferase 1 | Soms (5–29%) | In 1 aandoening |
| LMOD3leiomodin 3 | Soms (5–29%) | In 1 aandoening |
| LRP4LDL receptor related protein 4 | Soms (5–29%) | In 1 aandoening |
| LTBP1latent transforming growth factor beta binding protein 1 | Soms (5–29%) | In 2 aandoeningen |
| MACF1microtubule actin crosslinking factor 1 | Soms (5–29%) | In 1 aandoening |
| MAD2L2mitotic arrest deficient 2 like 2 | Soms (5–29%) | In 1 aandoening |
| MASP1MBL associated serine protease 1 | Soms (5–29%) | In 1 aandoening |
| MAU2MAU2 sister chromatid cohesion factor | Soms (5–29%) | In 1 aandoening |
| MBTPS2membrane bound transcription factor peptidase, site 2 | Soms (5–29%) | In 1 aandoening |
| MYH8myosin heavy chain 8 | Soms (5–29%) | In 2 aandoeningen |
| NEBnebulin | Soms (5–29%) | In 1 aandoening |
| NFIXnuclear factor I X | Soms (5–29%) | In 1 aandoening |
| NIPBLNIPBL cohesin loading factor | Soms (5–29%) | In 1 aandoening |
| NODALnodal growth differentiation factor | Soms (5–29%) | In 4 aandoeningen |
| OCRLOCRL inositol polyphosphate-5-phosphatase | Soms (5–29%) | In 2 aandoeningen |
| PALB2partner and localizer of BRCA2 | Soms (5–29%) | In 1 aandoening |
| PHLDB1pleckstrin homology like domain family B member 1 | Soms (5–29%) | In 1 aandoening |
| PIGLphosphatidylinositol glycan anchor biosynthesis class L | Soms (5–29%) | In 1 aandoening |
| PLCH1phospholipase C eta 1 | Soms (5–29%) | In 1 aandoening |
| POMT1protein O-mannosyltransferase 1 | Soms (5–29%) | In 1 aandoening |
| POMT2protein O-mannosyltransferase 2 | Soms (5–29%) | In 2 aandoeningen |
| PTCH1patched 1 | Soms (5–29%) | In 4 aandoeningen |
| PUF60poly(U) binding splicing factor 60 | Soms (5–29%) | In 2 aandoeningen |
| PYCR2pyrroline-5-carboxylate reductase 2 | Soms (5–29%) | In 1 aandoening |
| RAD21RAD21 cohesin complex component | Soms (5–29%) | In 1 aandoening |
| RAD51RAD51 recombinase | Soms (5–29%) | In 1 aandoening |
| RAD51CRAD51 paralog C | Soms (5–29%) | In 1 aandoening |
| RFWD3ring finger and WD repeat domain 3 | Soms (5–29%) | In 1 aandoening |
| ROR2ROR family WNT receptor 2 | Soms (5–29%) | In 1 aandoening |
| SCYL2SCY1 like pseudokinase 2 | Soms (5–29%) | In 1 aandoening |
| SHHsonic hedgehog signaling molecule | Soms (5–29%) | In 4 aandoeningen |
| SIX3SIX homeobox 3 | Soms (5–29%) | In 4 aandoeningen |
| SLC26A2solute carrier family 26 member 2 | Soms (5–29%) | In 1 aandoening |
| SLC2A10solute carrier family 2 member 10 | Soms (5–29%) | In 1 aandoening |
| SLC6A5solute carrier family 6 member 5 | Soms (5–29%) | In 1 aandoening |
| SLX4SLX4 structure-specific endonuclease subunit | Soms (5–29%) | In 1 aandoening |
| SMC1Astructural maintenance of chromosomes 1A | Soms (5–29%) | In 2 aandoeningen |
| SMC3structural maintenance of chromosomes 3 | Soms (5–29%) | In 1 aandoening |
| SMOC1SPARC related modular calcium binding 1 | Soms (5–29%) | In 2 aandoeningen |
| STAG2STAG2 cohesin complex component | Soms (5–29%) | In 2 aandoeningen |
| STILSTIL centriolar assembly protein | Soms (5–29%) | In 4 aandoeningen |
| TFE3transcription factor binding to IGHM enhancer 3 | Soms (5–29%) | In 1 aandoening |
| TGIF1TGFB induced factor homeobox 1 | Soms (5–29%) | In 4 aandoeningen |
| TONSLtonsoku like, DNA repair protein | Soms (5–29%) | In 1 aandoening |
| TPM2tropomyosin 2 | Soms (5–29%) | In 1 aandoening |
| UBE2Tubiquitin conjugating enzyme E2 T | Soms (5–29%) | In 1 aandoening |
| VAC14VAC14 component of PIKFYVE complex | Soms (5–29%) | In 1 aandoening |
| WNT5AWnt family member 5A | Soms (5–29%) | In 1 aandoening |
| WNT7AWnt family member 7A | Soms (5–29%) | In 1 aandoening |
| XRCC2X-ray repair cross complementing 2 | Soms (5–29%) | In 1 aandoening |
| ZIC2Zic family zinc finger 2 | Soms (5–29%) | In 4 aandoeningen |
| EBF3EBF transcription factor 3 | Zelden (1–4%) | In 1 aandoening |
| ATRATR checkpoint kinase | Niet vastgelegd | In 1 aandoening |
| B3GAT3beta-1,3-glucuronyltransferase 3 | Niet vastgelegd | In 1 aandoening |
| C12orf57chromosome 12 open reading frame 57 | Niet vastgelegd | In 1 aandoening |
| CD96CD96 molecule | Niet vastgelegd | In 1 aandoening |
| CHRNGcholinergic receptor nicotinic gamma subunit | Niet vastgelegd | In 1 aandoening |
| CHST3carbohydrate sulfotransferase 3 | Niet vastgelegd | In 1 aandoening |
| COL2A1collagen type II alpha 1 chain | Niet vastgelegd | In 2 aandoeningen |
| CPLX1complexin 1 | Niet vastgelegd | In 1 aandoening |
| CTBP1C-terminal binding protein 1 | Niet vastgelegd | In 1 aandoening |
| CUL7cullin 7 | Niet vastgelegd | In 1 aandoening |
| EIF2AK3eukaryotic translation initiation factor 2 alpha kinase 3 | Niet vastgelegd | In 1 aandoening |
| EXOSC3exosome component 3 | Niet vastgelegd | In 1 aandoening |
| FGFRL1fibroblast growth factor receptor like 1 | Niet vastgelegd | In 1 aandoening |
| GJA1gap junction protein alpha 1 | Niet vastgelegd | In 1 aandoening |
| HOXA11homeobox A11 | Niet vastgelegd | In 1 aandoening |
| IFIH1interferon induced with helicase C domain 1 | Niet vastgelegd | In 1 aandoening |
| LETM1leucine zipper and EF-hand containing transmembrane protein 1 | Niet vastgelegd | In 1 aandoening |
| MYH3myosin heavy chain 3 | Niet vastgelegd | In 1 aandoening |
| NSD2nuclear receptor binding SET domain protein 2 | Niet vastgelegd | In 1 aandoening |
| OSGEPO-sialoglycoprotein endopeptidase | Niet vastgelegd | In 1 aandoening |
| SF3B4splicing factor 3b subunit 4 | Niet vastgelegd | In 1 aandoening |
| SLC12A2solute carrier family 12 member 2 | Niet vastgelegd | In 1 aandoening |
| SLC6A9solute carrier family 6 member 9 | Niet vastgelegd | In 1 aandoening |
| SMOsmoothened, frizzled class receptor | Niet vastgelegd | In 1 aandoening |
| TNNT3troponin T3, fast skeletal type | Niet vastgelegd | In 1 aandoening |
| USP9Xubiquitin specific peptidase 9 X-linked | Niet vastgelegd | In 1 aandoening |
| ZC4H2zinc finger C4H2-type containing | Niet vastgelegd | In 2 aandoeningen |
Hoe vaak dit voorkomt bij mensen met een van de aandoeningen van het gen, de hoogste frequentie binnen die aandoeningen, zoals de Human Phenotype Ontology dit vastlegt. Deze pagina's beschrijven kenmerken en het onderzoek erachter; het zijn geen diagnose, en over symptomen kunt u het best een arts of genetisch adviseur raadplegen.
Smallere kenmerken
Bredere kenmerken
Waar dit vandaan komt
- De Human Phenotype Ontology, release 2026-09-01: het kenmerk, de namen, de definitie en de genen die ermee verbonden zijn. Meer informatie vindt u op hpo.jax.org.
- Gegevensrelease 2026.10.16-c6eea6bf.
Eén test. Een leven lang antwoorden.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken